Asymchem Laboratories (Tianjin) Co., Ltd. (SHE: 002821)

Market Cap	21.31B
Revenue (ttm)	5.88B
Net Income (ttm)	1.08B
Shares Out	354.88M
EPS (ttm)	3.02
PE Ratio	20.54
Forward PE	17.68
Dividend	1.80 (2.96%)
Ex-Dividend Date	Jun 28, 2024

Volume	3,896,904
Open	62.77
Previous Close	60.84
Day's Range	60.60 - 62.89
52-Week Range	59.55 - 165.27
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Asymchem Laboratories (Tianjin)

Asymchem Laboratories (Tianjin) Co., Ltd. engages in the provision of contract development and manufacturing services focuses on innovation and commercial application of global pharmaceutical technology in Mainland China and internationally. The company offers research and development, and production services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulat...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 9,788
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2023, Asymchem Laboratories (Tianjin)'s revenue was 7.83 billion, a decrease of -23.70% compared to the previous year's 10.26 billion. Earnings were 2.27 billion, a decrease of -31.28%.